According to Dave Muoio, “By combining the best innovations in diabetic footwear technology and Sensoria Core microelectronics, we can contribute to help clinicians and diabetic patients reduce risk of amputations,” Davide Vigano, co founder and CEO of Sensoria Health, told MobiHealthNews in an email.
According to a statement, the device uses pressure sensors and other technologies developed by Sensoria alongside Optima Molliter’s clinically validated offloading system, which reduces weight and pressure on a patient’s injured foot.
To avoid infection, amputation, and potential mortality, clinicians prescribe specialized footwear to diabetes patients with foot complications. Some of these are full contact or come equipped with non-removable compliance systems, both of which are uncomfortable and not always tolerated by patients. As an alternative, the Motus Smart communicates via text messages and a web dashboard to inform caregivers and clinicians of patient non-compliance.Recording a patient’s compliance and usage patterns will reduce risk of amputations and provide objective data to the treating physician or hospital center that manages the patient.By giving information on the usage patterns, deambulatory activity, and concentration of the patient’s orthotic pressures, hospitals will provide additional evidence to a patient’s adherence to the mechanical offloading treatment.”
“Offloading is essential to diabetic foot ulcer healing, according to podiatry consensus guidelines,” Vigano said in a statement. “Motus Smart will significantly improve the lives of people that suffer from diabetic foot complications. With Sensoria’s technology, caregivers, and clinicians will have access to multitudes of patient data, allowing them to track compliance and intervene before amputation becomes unavoidable.”
Get Smarter with the use of Smart shoes in future. Click here